• About Us
    • Our Team
    • Our Work
    • In The News
  • Resources
    • Curated Research Library
    • Popular Articles
    • Legal Beagle Archive
    • The Education Program
    • VCS Vet Research Program
  • Directory of Practitioners
  • Get Involved
    • Become A Sponsor
    • Join Email List
  • Contact
  • SHOP NOW
    • VCS APPAREL
    • PET & PARENT JEWELRY
  • DONATE
  • Members Dashboard
Veterinary Cannabis SocietyVeterinary Cannabis Society
  • About Us
    • Our Team
    • Our Work
    • In The News
  • Resources
    • Curated Research Library
    • Popular Articles
    • Legal Beagle Archive
    • The Education Program
    • VCS Vet Research Program
  • Directory of Practitioners
  • Get Involved
    • Become A Sponsor
    • Join Email List
  • Contact
  • SHOP NOW
    • VCS APPAREL
    • PET & PARENT JEWELRY
  • DONATE
  • Members Dashboard

Archive

Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.

Apr 21, 2021

Abstract The ATP-dependent drug efflux transporter P-glycoprotein (P-gp) plays a significant role in the absorption and disposition of many compounds....

CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells

Apr 21, 2021

Abstract Background: Cannabis is the most widely used illicit drug in the world that is often used by cancer patients in...

Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation

Apr 21, 2021

Abstract Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells and is typically well treated with combination...

Cannabidiol Reduces Leukemic Cell Size – But Is It Important?

Apr 21, 2021

Abstract The anti-cancer effect of the plant-derived cannabinoid, cannabidiol, has been widely demonstrated both in vivo and in vitro. However, this body of...

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma

Apr 21, 2021

Abstract Background: Neuroblastoma (nbl) is one of the most common solid cancers in children. Prognosis in advanced nbl is still poor...

A pilot clinical study of Δ -tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

Apr 21, 2021

Abstract Delta(9)-Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth and angiogenesis in animal models, so their potential application as antitumoral...

A combined preclinical therapy of cannabinoids and temozolomide against glioma

Apr 21, 2021

Abstract Glioblastoma multiforme (GBM) is highly resistant to current anticancer treatments, which makes it crucial to find new therapeutic strategies...

The use of cannabis in supportive care and treatment of brain tumor

Apr 21, 2021

Abstract Cannabinoids are multitarget substances. Currently available are dronabinol (synthetic delta-9-tetrahydrocannabinol, THC), synthetic cannabidiol (CBD) the respective substances isolated and...

The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care

Apr 21, 2021

Abstract Background. Cancer patients using cannabis report better influence from the plant extract than from synthetic products. However, almost all...

The endocannabinoid system: Novel targets for treating cancer induced bone pain

Apr 21, 2021

Abstract Treating Cancer-induced bone pain (CIBP) continues to be a major clinical challenge and underlying mechanisms of CIBP remain unclear....

  • 1
  • 2
  • …
  • 29
  • 30
  • 31
  • …
  • 40
  • 41

Search Our Website

Recent In The News

  • CBD Oracle Interviews VCS Board and Sponsors
  • New York Times: Mammals with the Munchies
  • Check out this article highlighting VCS in the newest issue of “Cannabis and Tech Today.
  • BREAKING NEWS! Check out this recently released statement from the U.S. Food and Drug Administration about next steps to explore potential regulatory pathways for CBD products!
  • Cannabis in Veterinary Medicine | Continual Education | VIN
  • Check out this conversation with VCS Founders Dr. Gary Richter, Dr. Trina Hazzah, and Charles Lozow on the importance of advocating for the safe use of cannabis in pets
  • A Dose Finding Study of Cannabidiol in Dogs with Intractable Epilepsy
  • Earth Buddy, Pet Calming Study – Press Release
  • CALIFORNIA CANNABIS UPDATES – April 2022
  • Cannabis in Veterinary Practice Multi-Expert Webinar

Our Mission is to create lasting solutions that ensure the safe use of cannabis in pets through education, advocacy, and promoting product standards.

Our Vision is an educated and empowered global veterinary medical cannabis community.

  • About Us
  • Our Work
  • Get Involved
  • Contact Us
  • Donate

Email:
Click here to email us

Florida Mailing Address
7901 4th St. North, Suite 4404
St. Petersburg, FL 33702

Veterinary Cannabis Society is a nonprofit, 501(c)(3) organization in the United States. Tax ID #85-0986090

Veterinary Cannabis Society does not endorse any specific products.

© 2025 · Veterinary Cannabis Society

  • Terms of Use
  • Privacy Policy
  • State Notices
  • Contact